Intellia Therapeutics, Inc. - COM (NTLA)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / COM
Number of holders
276
Total Shares
93.1M
Shares change
+2.78M
Total reported value, excl. options
$1.91B
Value change
+$51.1M
Put/Call ratio
1.96
Number of buys
146
Number of sells
-131
Price
$20.55
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.